Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy: A Losartan Intervention For Endpoint Reduction (LIFE) Substudy
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
CONTEXT: Drug intervention in placebo-controlled trials has been beneficial in isolated systolic hypertension. OBJECTIVE: To test the hypothesis that losartan improves outcome better than atenolol in patients with isolated systolic hypertension and electrocardiographically documented left ventricular hypertrophy (ECG-LVH). DESIGN: Double-blind, randomized, parallel-group study conducted in 1995-2001. SETTING AND PARTICIPANTS: A total of 1326 men and women aged 55 through 80 years (mean, 70 years) with systolic blood pressure of 160 to 200 mm Hg and diastolic blood pressure of less than 90 mm Hg (mean, 174/83 mm Hg) and ECG-LVH, recruited from 945 outpatient settings in the Nordic countries, the United Kingdom, and the United States. INTERVENTIONS: Patients were randomly assigned to receive once-daily losartan (n = 660) or atenolol (n = 666) with hydrochlorothiazide as the second agent in both arms, for a mean of 4.7 years. MAIN OUTCOME MEASURE: Composite end point of cardiovascular death, stroke, or myocardial infarction. RESULTS: Blood pressure was reduced by 28/9 and 28/9 mm Hg in the losartan and atenolol arms. The main outcome was reduced by 25% with losartan compared with atenolol, 25.1 vs 35.4 events per 1000 patient-years (relative risk [RR], 0.75; 95% confidence interval [CI], 0.56-1.01; P =.06, adjusted for risk and degree of ECG-LVH; unadjusted RR, 0.71; 95% CI, 0.53-0.95; P =.02). Patients receiving losartan had reductions in the following without a difference in the incidence of myocardial infarction: cardiovascular mortality (8.7 vs 16.9 events per 1000 patient-years; RR, 0.54; 95% CI, 0.34-0.87; P =.01), nonfatal and fatal stroke (10.6 vs 18.9 events per 1000 patient-years; RR, 0.60; 95% CI, 0.38-0.92; P =.02), new-onset diabetes (12.6 vs 20.1 events per 1000 patient-years; RR, 0.62; 95% CI, 0.40-0.97; P =.04), and total mortality (21.2 vs 30.2 events per 1000 patient-years; RR, 0.72; 95% CI, 0.53-1.00; P =.046). Losartan decreased ECG-LVH more than atenolol (P<.001) and was better tolerated. CONCLUSION: These data suggest that losartan is superior to atenolol for treatment of patients with isolated systolic hypertension and ECG-LVH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Self-citationStaessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
An updated coronary risk profile. A statement for health professionals.
Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Self-citationSystolic versus diastolic blood pressure and risk of coronary heart disease
Kannel, W. B., Gordon, T., & Schwartz, M. J. (1971) · The American Journal of Cardiology · doi:10.1016/0002-9149(71)90428-0 · Cited by 925
Reversal of Left Ventricular Hypertrophy in Hypertensive Patients
Dahlöf, B., Pennert, K., & Hansson, L. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.2.95 · Cited by 925
Self-citationLiu, L., Wang, J. G., Gong, L., Liu, G., & Staessen, J. A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816120-00016 · Cited by 730
Levy, D., Salomon, M., D'Agostino, R. B., Belanger, A. J., & Kannel, W. B. (1994) · Circulation · doi:10.1161/01.cir.90.4.1786 · Cited by 619
Schiffrin, E. L., Park, J. B., Intengan, H. D., & Touyz, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.14.1653 · Cited by 616
Casale, P. N., Devereux, R. B., Alonso, D. R., Campo, E., & Kligfield, P. (1987) · Circulation · doi:10.1161/01.cir.75.3.565 · Cited by 561
Self-citationMesserli, F. H., Grossman, E., & Goldbourt, U. (1998) · JAMA · doi:10.1001/jama.279.23.1903 · Cited by 561
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study
Kannel, W. B. (1981) · JAMA · doi:10.1001/jama.245.12.1225 · Cited by 489
Okin, P. M., Roman, M. J., Devereux, R. B., & Kligfield, P. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00371-v · Cited by 395
Self-citationKjekshus, J. K. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90888-x · Cited by 357
Muiesan, M. L., Salvetti, M., Rizzoni, D., Castellano, M., Donato, F., & Agabiti-Rosei, E. (1995) · Journal of Hypertension · doi:10.1097/00004872-199510000-00003 · Cited by 328
(1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00054-x · Cited by 307
Characteristics of 9194 Patients With Left Ventricular Hypertrophy: The LIFE Study
Dahlöf, B., Devereux, R. B., Julius, S., Kjeldsen, S. E., Beevers, G., de Faire, U., Fyhrquist, F., Hedner, T., Ibsen, H., Kristianson, K., et al. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.989 · Cited by 294
Self-citationVerdecchia, P., Porcellati, C., Reboldi, G., Gattobigio, R., Borgioni, C., Pearson, T. A., & Ambrosio, G. (2001) · Circulation · doi:10.1161/hc4201.097944 · Cited by 292
Mortality in Patients of the Glasgow Blood Pressure Clinic
Isles, C. G., Walker, L. M., Beevers, G. D., Brown, I., Cameron, H. L., Clarke, J., Hawthorne, V., Hole, D., Lever, A. F., Robertson, J. W. K., et al. (1986) · Journal of Hypertension · doi:10.1097/00004872-198604000-00003 · Cited by 261
Self-citationImproved electrocardiographic diagnosis of left ventricular hypertrophy
Schillaci, G., Verdecchia, P., Borgioni, C., Ciucci, A., Guerrieri, M., Zampi, I., Battistelli, M., Bartoccini, C., & Porcellati, C. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90316-6 · Cited by 248
Samuelsson, O. (1987) · JAMA · doi:10.1001/jama.258.13.1768 · Cited by 191
Devereux, R. B., Agabiti-Rosei, E., Dahl??f, B., Gosse, P., Hahn, R. T., Okin, P. M., & Roman, M. J. (1996) · Journal of Hypertension · doi:10.1097/00004872-199609002-00018 · Cited by 176
Self-citationKjeldsen, S. E., Julius, S., Hedner, T., & Hansson, L. (2001) · Blood Pressure · doi:10.1080/08037050152669684 · Cited by 129
Self-citationNorman, J. E., & Levy, D. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00269-5 · Cited by 112
Okin, P. M., Roman, M. J., Devereux, R. B., & Kligfield, P. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00421-1 · Cited by 109
Self-citationAngiotensin II Receptor Antagonists: An Emerging New Class of Cardiovascular Therapeutics.
Timmermans, P. B. M. W. M. (1999) · Hypertension Research · doi:10.1291/hypres.22.147 · Cited by 106
Dahlöf, B., Keller, S. E., Makris, L., Goldberg, A. I., Sweet, C. S., & Lim, N. Y. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00081-y · Cited by 103
Self-citationLINDHOLM, L., EJLERTSSON, G., & SCHERSTÉN, B. (1984) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1984.tb03802.x · Cited by 80
Self-citationBrunner, H. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01538-7 · Cited by 74
Kjeldsen, S. E., Dahlof, B., Devereux, R. B., Julius, S., de Faire, U., Fyhrquist, F., Ibsen, H., Kristianson, K., Lederballe-Pedersen, O., Lindholm, L. H., et al. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00280-6 · Cited by 60
Self-citation
Cited by
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Self-citationMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Self-citationACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
Metadata
- Authors
- Kjeldsen, S. E., Dahlöf, B., Devereux, R. B., Julius, S., Aurup, P., Edelman, J., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristianson, K., Lederballe-Pedersen, O., Lindholm, L. H., Nieminen, M. S., Omvik, P., Oparil, S., Snapinn, S., Wedel, H., & for the LIFE Study Group
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-09-25
- Volume
- 288
- Issue
- 12
- Pages
- 1491
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2130136596
- Cited by
- 443
- References
- 33
- FWCI
- 33.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.